{"c":"H8010","name":"CLOVER HMO OF NEW JERSEY INC.","parent":"Clover Health Holdings, Inc.","members":3835,"m":[["Breast Cancer Screening","4","5","79%",-1],["Colorectal Cancer Screening","5","5","83%",0],["Annual Flu Vaccine","4","2","69%",2],["Improving or Maintaining Physical Health","3","Not enough data available","72%",null],["Improving or Maintaining Mental Health","4","Not enough data available","85%",null],["Monitoring Physical Activity","4","4","58%",0],["Special Needs Plan (SNP) Care Management","Plan not required to report measure","Plan not required to report measure","Plan not required to report measure",null],["Care for Older Adults - Medication Review","Plan not required to report measure","Plan not required to report measure","Plan not required to report measure",null],["Care for Older Adults - Functional Status Assessment","Plan not required to report measure",null,"Plan not required to report measure",null],["Osteoporosis Management in Women who had a Fracture","Not enough data available","Not enough data available","Not enough data available",null],["Diabetes Care - Eye Exam","5","5","90%",0],["Diabetes Care - Blood Sugar Controlled","5","5","92%",0],["Kidney Health Evaluation for Patients with Diabetes","4","4","78%",0],["Controlling High Blood Pressure","4","5","88%",-1],["Reducing the Risk of Falling","4","3","65%",1],["Improving Bladder Control","Not enough data available","Not enough data available","Not enough data available",null],["Plan All-Cause Readmissions","5","4","6%",1],["Statin Therapy for Patients with Cardiovascular Disease","5","5","95%",0],["Transitions of Care","5","5","83%",0],["Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions","4","5","77%",-1],["Getting Needed Care","4","3","85",1],["Getting Appointments and Care Quickly","Not enough data available","4","Not enough data available",null],["Customer Service","4","3","91",1],["Rating of Health Care Quality","3","3","87",0],["Rating of Health Plan","4","4","88",0],["Care Coordination","Not enough data available","3","Not enough data available",null],["Complaints about the Health Plan","4","3","0.18",1],["Members Choosing to Leave the Plan","4","4","17%",0],["Health Plan Quality Improvement","4","5","Medicare shows only a Star Rating for this topic",-1],["Plan Makes Timely Decisions about Appeals","5","5","100%",0],["Reviewing Appeals Decisions","5","3","100%",2],["Call Center - Foreign Language Interpreter and TTY Availability","4","3","98%",1],["Complaints about the Drug Plan","4","3","0.18",1],["Drug Plan Quality Improvement","5","5","Medicare shows only a Star Rating for this topic",0],["Rating of Drug Plan","4","4","87",0],["Getting Needed Prescription Drugs","Not enough data available","Not enough data available","Not enough data available",null],["MPF Price Accuracy","4","5","99",-1],["Medication Adherence for Diabetes Medications","2","1","87%",1],["Medication Adherence for Hypertension (RAS antagonists)","4","2","91%",2],["Medication Adherence for Cholesterol (Statins)","4","1","90%",3],["Statin Use in Persons with Diabetes (SUPD)","4","4","92%",0],["Concurrent Use of Opioids and Benzodiazepines (COB)","4",null,"12%",null],["Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults (Poly-ACH)","3",null,"8%",null]],"src":"CMS 2027 Star Ratings Data Tables (Oct 8, 2026), Measure Stars and Measure Data; CMS 2026 Star Ratings Data Tables (Oct 8, 2025); CMS CPSC enrollment October 2026"}